Credit Suisse Starts Genomic Health Inc. (GHDX) at Outperform
Tweet Send to a FriendGet Alerts GHDX Hot Sheet
Price: $37.25 +1.92%
Rating Summary:
7 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
7 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade GHDX Now!
Credit Suisse initiates coverage on Genomic Health Inc. (NASDAQ: GHDX) with a Outperform. PT $43.00.
For an analyst ratings summary and ratings history on Genomic Health Inc. click here. For more ratings news on Genomic Health Inc. click here.
Shares of Genomic Health Inc. closed at $34.98 yesterday, with a 52 week range of $19.18-$37.44.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Genomic Health Inc. click here. For more ratings news on Genomic Health Inc. click here.
Shares of Genomic Health Inc. closed at $34.98 yesterday, with a 52 week range of $19.18-$37.44.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Topeka Capital Starts Laredo Petroleum (LPI) at Buy, Assets 'Undervalued'
- Barclays Starts Leap Wireless (LEAP) at Underweight
- Barclays Starts American Tower (AMT) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Credit Suisse
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
